Related references
Note: Only part of the references are listed.The impact of disease severity measures on survival in US Veterans with rheumatoid arthritis-associated interstitial lung disease
Rebecca Brooks et al.
RHEUMATOLOGY (2022)
IL-33/ST2 axis in autoimmune disease
Leila Shakerian et al.
CYTOKINE (2022)
Disease activity, cytokines, chemokines and the risk of incident diabetes in rheumatoid arthritis
Joshua F. Baker et al.
ANNALS OF THE RHEUMATIC DISEASES (2021)
The impact of airborne endotoxin exposure on rheumatoid arthritis-related joint damage, autoantigen expression, autoimmunity, and lung disease
Ted R. Mikuls et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2021)
IL-33-mediated Eosinophilia Protects against Acute Lung Injury
Paulette A. Krishack et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2021)
Quantitation of reduced IL-33 levels in human serum: mitigating interference from endogenous binding partners
Joshua Zylstra et al.
BIOANALYSIS (2021)
Autoantibody Seropositivity and Risk for Interstitial Lung Disease in a Prospective Male-Predominant Rheumatoid Arthritis Cohort of US Veterans
Jake G. Natalini et al.
ANNALS OF THE AMERICAN THORACIC SOCIETY (2021)
Performance of Administrative Algorithms to Identify Interstitial Lung Disease in Rheumatoid Arthritis
Bryant R. England et al.
ARTHRITIS CARE & RESEARCH (2020)
Thymic stromal lymphopoietin protects in a model of airway damage and inflammation via regulation of caspase-1 activity and apoptosis inhibition
Nicholas J. Shubin et al.
MUCOSAL IMMUNOLOGY (2020)
Blocking Interleukin-33 Alleviates the Joint Inflammation and Inhibits the Development of Collagen-Induced Arthritis in Mice
Yan Li et al.
JOURNAL OF IMMUNOLOGY RESEARCH (2020)
Immune- and non-immune-mediated roles of regulatory T-cells during wound healing
Dietmar M. Zaiss et al.
IMMUNOLOGY (2019)
Macrophage-secreted TSLP and MMP9 promote bleomycin-induced pulmonary fibrosis
Guanqun Li et al.
TOXICOLOGY AND APPLIED PHARMACOLOGY (2019)
Malondialdehyde-Acetaldehyde Adducts and Antibody Responses in Rheumatoid Arthritis-Associated Interstitial Lung Disease
Bryant R. England et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Epithelial Alarmins in Serum and Exhaled Breath in Patients with Idiopathic Pulmonary Fibrosis: A Prospective One-Year Follow-Up Cohort Study
Sebastian Majewski et al.
JOURNAL OF CLINICAL MEDICINE (2019)
IL-33/ST2 Axis in Organ Fibrosis
Ourania S. Kotsiou et al.
FRONTIERS IN IMMUNOLOGY (2018)
IL-33: biological properties, functions, and roles in airway disease
Li Yin Drake et al.
IMMUNOLOGICAL REVIEWS (2017)
Upregulation of interleukin-33 and thymic stromal lymphopoietin levels in the lungs of idiopathic pulmonary fibrosis
Jong-Uk Lee et al.
BMC PULMONARY MEDICINE (2017)
Lentivirus expressing soluble ST2 alleviates bleomycin-induced pulmonary fibrosis in mice
Qiaoyan Gao et al.
INTERNATIONAL IMMUNOPHARMACOLOGY (2016)
IL-33/ST2 pathway in a bleomycin-induced pulmonary fibrosis model
Jiao Xu et al.
MOLECULAR MEDICINE REPORTS (2016)
Serum IL-33 Is a Novel Diagnostic and Prognostic Biomarker in Acute Ischemic Stroke
Qian Li et al.
Aging and Disease (2016)
Serum level of interleukin-33 in rheumatoid arthritis patients and its association with bone erosion and interstitial lung disease
Shimma M. Abdel-Wahab et al.
EGYPTIAN RHEUMATOLOGIST (2016)
The Protective Role of Interleukin-33 in Myocardial Ischemia and Reperfusion Is Associated with Decreased HMGB1 Expression and Up-Regulation of the P38 MAPK Signaling Pathway
Ma Ruisong et al.
PLOS ONE (2015)
Emerging role of interleukin-33 in autoimmune diseases
Cheng Pei et al.
IMMUNOLOGY (2014)
Interleukin-33 Potentiates Bleomycin-Induced Lung Injury
Irina G. Luzina et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2013)
Increased levels of interleukin-33 associated with bone erosion and interstitial lung diseases in patients with rheumatoid arthritis
Zhu Xiangyang et al.
CYTOKINE (2012)
IL-33 is processed into mature bioactive forms by neutrophil elastase and cathepsin G
Emma Lefrancais et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Rheumatoid Arthritis-Interstitial Lung Disease-associated Mortality
Amy L. Olson et al.
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2011)
The IL1-like cytokine IL33 and its receptor ST2 are abnormally expressed in the affected skin and visceral organs of patients with systemic sclerosis
Mirko Manetti et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Anti-CCP antibody and rheumatoid factor concentrations predict greater disease activity in men with rheumatoid arthritis
Benjamin J. Miriovsky et al.
ANNALS OF THE RHEUMATIC DISEASES (2010)
Incidence and Mortality of Interstitial Lung Disease in Rheumatoid Arthritis
Tim Bongartz et al.
ARTHRITIS AND RHEUMATISM (2010)
IL-33 Exacerbates Autoantibody-Induced Arthritis
Damo Xu et al.
JOURNAL OF IMMUNOLOGY (2010)
Elevated Serum Interleukin 33 Is Associated with Autoantibody Production in Patients with Rheumatoid Arthritis.
Rong Mu et al.
JOURNAL OF RHEUMATOLOGY (2010)
Interleukin-33 Prevents Apoptosis and Improves Survival After Experimental Myocardial Infarction Through ST2 Signaling
Kenjiro Seki et al.
CIRCULATION-HEART FAILURE (2009)
IL-33, an interleukin-1-like cytokine that signals via the IL-1 receptor-related protein ST2 and induces T helper type 2-associated cytokines
J Schmitz et al.
IMMUNITY (2005)
Share Paper
